explore -WSS

explore

author：leisure time 2025-10-06 14:01:45 - browse：445

The FDA building -- First Opinion coverage from STAT — Adobe

A panel of independent advisers to the Food and Drug Administration voted overwhelmingly against a polarizing potential treatment for ALS on Wednesday, concluding that the medicine’s messy supporting data did not meet the standard for approval.

After a day-long meeting that included impassioned testimony from ALS patients, the agency’s expert advisers voted 17-1 with one abstention that the case for NurOwn, a treatment from BrainStorm Cell Therapeutics, was based too heavily on convoluted clinical trial results and compelling but unreliable anecdotal evidence.

“Patients and families need hope, but providing false hope can be ethically problematic,” said panelist Lisa Lee, a bioethicist at Virginia Tech. “False hope is provided when the probability of a positive outcome is overestimated, and I think that seems to be the case here.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Medicare details structure of new drug price negotiation program
Next article： Lawsuit highlights wrinkle for disputes over surprise medical bills

explore

WSS

2023 Nobel Prize in Medicine goes to Karikó and Weissman

Health insurers' Q3 question: how much care are people getting?

The stability of $0 premiums in Medicare Advantage

Community Health Systems hospitals under DOJ investigation

New oral drug delivery patch is modeled after octopus tentacles

What we owe ALS patients — and why one company fell short

explore

explore

leisure time

Medical records are filled with copy

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Over 800 arrested across France in 3rd night of riots after fatal police shooting of teen

Stop Congress from blocking public access to science

DIEP, the 'gold standard' of breast reconstruction, is under threat

Neurocrine Biosciences, biotech based in San Diego, joins PhRMA

Malaria cases in Florida and Texas: Here’s what you need to know

With Roe v Wade overturned, abortion providers work to adapt

Jerome Adams on the need for new antivirals for Covid

Will an HIV vaccine ever be a reality?

Wikipedia

NIH study of ME/CFS points to clear biological hallmarks

Congress extends some pandemic preparedness programs

Medicare innovation center doesn’t save money, experts say

Lawsuit highlights wrinkle for disputes over surprise medical bills

Obesity drugs seen as possible treatment for liver disease MASH

FDA sees ‘potential systemic bias’ in Amgen’s KRAS drug trial

focus

explore

leisure time

focus